Health ❯ Pharmaceuticals

Drug Regulation

FDA Quality Control Counterfeit Drugs Fixed Dose Combinations GLP-1 Drugs Market Surveillance Prescription Drugs Clinical Trials Enforcement Actions FDA Decisions

FDA Asks Drugmakers for More Data on Testosterone Use in Menopausal Women

This could open a pathway to female-specific approvals if trials resolve unanswered risks to heart and breast health.

Medsafe Authorises Two Psychiatrists to Deliver MDMA Therapy for Severe PTSD

Telangana Creates TG SAFE by Merging Food Safety and Drugs Control

India Gives Regulators Power to Debar Firms for Fabricated Drug Data

Telangana Seizes Gabapentin Tablets Sold as Nutraceuticals

FDA Reviews Influencer-Driven Peptides as Panel Weighs Compounding Access

Cofepris Warns of Falsified Bayer Products and Stolen Medikinet

Illegal Weight‑Loss Pens Labeled As Experimental Drug Flood Brazil's Market

Anvisa Orders COVID-19 Vaccines Be Monovalent Targeting LP.8.1 or JN.1 Antigens

FDA Scientists Say Evidence Lacks for Allowing Seven Popular Peptides in Compounding

India Cancels Licences After Spurious Oxytocin Batch Linked to Maternal Deaths

India Requires Unique QR Codes on Vaccines, Antibiotics and Cancer Drugs

India Bans 16 Fixed‑Dose Combination Drugs

FDA Approves Colorado Plan to Import 20 Prescription Drugs From Canada

Digemid Closes 666 Pharmacies After Nationwide Inspections

India Reclassifies Pregabalin as Schedule H1

ImmunityBio Investors Face May 26 Lead-Plaintiff Deadline in Securities Suit Tied to FDA Anktiva Rebuke

Appeals Court Halts Mail Delivery of Abortion Pill Mifepristone Nationwide

Telangana Drug Regulator Flags 75 Pharmacies in GLP-1 Sales Crackdown

Gurugram Bust Exposes Counterfeit Mounjaro Operation With Suspected China Link